Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Schedule One - Ovoca Bio Plc

31 Dec 2025 08:00

RNS Number : 2768N
AIM
31 December 2025
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

 

Ovoca Bio Plc ("Ovoca") to be renamed Talisman Metals plc on Admission ("Talisman" or the "Company")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES):

 

17 Pembroke Street Upper

Dublin 2

D02 AT22

Ireland

 

COUNTRY OF INCORPORATION:

 

Ireland

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

https://www.ovocabioplc.com to be www.talismanmetalsplc.com after re-Admission

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

On 7 May 2025, Ovoca announced it had entered into a conditional Letter of Intent ("LOI") to acquire 100% of Tadeen, a UK-registered company, which indirectly owns 100% of the Licences in Morocco, prospective for Copper and Silver (the "Acquisition"), through its wholly owned subsidiary, Horizons Mines SARL.

 

Tadeen was incorporated in 2021 and since that time has sought to develop and subsequently commercialise mineral exploration and exploitation properties with strong geological potential in the promising jurisdiction of Morocco. The Company will only focus its work on 10 of the exploration permits, five comprising the Tizert Project and five making up the Argana Project, with a total combined area of 129.8km2 (together the "Exploration Permits" for the purposes of this Document). These are between 8 and 30km from the large Tizert Copper-Silver Project being developed by the Managem SA Group (Managem) the Moroccan listed Mining Group for which the Government owns a majority stake. On completion of the Transaction, various members of the senior management team of Tadeen will be integrated into the Enlarged Group. The existing Chief Executive Officer of Ovoca, Timothy McCutcheon, will serve as Chief Executive Officer of the Enlarged Group.

 

The Transaction constitutes a reverse takeover under AIM Rule 14, requiring the approval of a majority of the Shareholders voting in person or by proxy at a general meeting

 

On Admission, Talisman Metals plc will, through its wholly owned Bermudan subsidiary T Metals Limited, will own 100% of Tadeen (the acquisition target) which in turn holds 100% of Horizons Mines SARL who own the Exploration Permits.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

Number of ordinary shares of €0.02 each ("Ordinary Shares") for which Admission is being sought: 64,174,918

 

The Ordinary Shares are and will remain freely transferable and have no restrictions as to transfer placed on them.

 

The issue price: 7.7 pence (the "Issue Price").

 

No Shares are or will be held in treasury.

 

CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

Capital to be raised on Admission: £1.155 million

 

Anticipated market capitalisation on Admission: approximately £4.9 million (at the Issue Price)

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

39.01%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:

 

N/A

 

THE COMPANY HAS APPLIED FOR THE VOLUNTARY CARBON MARKET DESIGNATION (Y/N)

 

No

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Timothy ("Tim") Rand McCutcheon - Chief Executive Officer

Leah Ellen O'Donovan - Chief Financial Officer

Jonathan George Henry - Independent Non-Executive Chair

Anastasia Levashova - Independent Non-Executive Director

Thomas ("Tom") Alan Garagan - Independent Non-Executive Director

Dr Mohammed Mouhib - Non-Executive Director

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

 

 

 

Name

Number of Ordinary Shares before Admission

Percentage of Existing Ordinary Shares

Number of Ordinary Shares on Admission**

Percentage of Enlarged

Share Capital

Euoclear Nominees Limited*

67,913,860

76.77%

22,637,953

35.28%

Timothy McCutheon (CEO)*

19,506,203

22.05%

6,679,613

10.41%

Picko Trading Co Limited

10,002,077

11.31%

3,334,026

5.20%

National Settlement Depository*

9,893,214

11.18%

3,297,738

5.14%

Investor Services Nominees Limited*

4,158,532

4.70%

1,386,177

2.16%

Cambrian Limited

-

-

6,252,049

9.74%

Charterhouse Trustees Limited

-

-

6,252,049

9.74%

Aya Silver & Gold Inc.

-

-

3,000,000

4.67%

Zakariae Mouhib

-

-

2,925,610

4.56%

Mohamed Baoutoul

-

-

2,925,610

4.56%

 

 

 

* All of these shares are held through Euroclear Nominees Limited

** Following a 3:1 share consolidation

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

None

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 December

(ii) 30 June 2025

(iii) As follows:

- 30 June 2026 (audited accounts for the year ended 31 December 2025)

- 30 September 2026 (unaudited interim financial statements for 6 months ended 30 June 2026)

- 30 June 2027 (audited accounts for the year ended 31 December 2026)

 

EXPECTED ADMISSION DATE:

 

28 January 2026

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Beaumont Cornish Limited

5-10 Bolton Street

London

W1J 8BA

 

NAME AND ADDRESS OF BROKER:

 

CMC Markets UK plc

 

133 Houndsditch

London

EC3A 7BX

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

The AIM Admission Document, which will contain full details of the applicant and admission of its securities, will be available from the Company's website:

 

https://www.ovocabioplc.com to be www.talismanmetalsplc.com after re-Admission

 

 

THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY

 

QCA Code

 

DATE OF NOTIFICATION:

 

31 December 2025

 

NEW/ UPDATE:

 

New

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PAAPKDBPABDKBBN
Date   Source Headline
25th Mar 20197:00 amRNSPrimary Endpoints Met in Libicore Phase III Study
31st Dec 20187:00 amRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSInterim Results
26th Sep 20187:00 amRNSCompletion of Acquisition of IVIX
3rd Aug 20187:00 amRNSChange of Name to Ovoca Bio plc
30th Jul 20188:05 amRNSReadmission to trading on AIM and ESM
30th Jul 20188:00 amRNSEnterprise Securities Market Notice
30th Jul 20187:00 amRNSESM - Cancellation Notice
27th Jul 20182:40 pmRNSResults of Meetings
4th Jul 201810:00 amRNSESM - Schedule One
4th Jul 201810:00 amRNSSchedule 1 - Ovoca Gold Plc
4th Jul 20187:00 amRNSProposed Acquisition of IVIX
25th May 20187:00 amRNSPublication of Annual Report
23rd Nov 20177:00 amRNSResult of AGM
30th Oct 20177:00 amRNSNotice of AGM
22nd Sep 20172:45 pmRNSHolding(s) in Company
20th Sep 20176:03 pmRNSDirector/PDMR Shareholding
15th Sep 20177:00 amRNSInterim Results
12th Sep 20177:00 amRNSHolding(s) in Company
28th Jul 20172:39 pmRNSChange of Registered Office Address
30th Jun 20177:00 amRNSPublication of Annual Report
14th Feb 20177:00 amRNSChange of Registered Office
17th Aug 20167:00 amRNSResults of AGM and EGM
16th Aug 201612:00 pmRNSInterim Results
5th Aug 20162:05 pmRNSSecond Price Monitoring Extn
5th Aug 20162:00 pmRNSPrice Monitoring Extension
15th Jul 20167:00 amRNSNotice of EGM
29th Jun 20167:00 amRNSAnnual Report and Notice of AGM
13th Oct 20158:31 amRNSDirector Dealings
7th Oct 201511:20 amRNSDirector Dealings
15th Sep 20154:40 pmRNSSecond Price Monitoring Extn
15th Sep 20154:35 pmRNSPrice Monitoring Extension
27th Aug 20159:37 amRNSResult of AGM
25th Aug 20157:00 amRNSInterim Results
30th Jun 20157:00 amRNSAnnual Report and Notice of AGM
29th Apr 20157:00 amRNSTransaction in Own Shares
17th Oct 20145:00 pmRNSResults of AGM and EGM
30th Sep 20147:00 amRNSHalf Yearly Report
24th Sep 20147:00 amRNSShare Buy Back & Deferred Consideration Payment
30th Jun 20147:00 amRNSAnnual Financial Report
22nd Oct 20137:00 amRNSResource Update
2nd Oct 20137:00 amRNSHolding(s) in Company
30th Sep 20137:00 amRNSInterim Results
25th Jun 20133:22 pmRNSResult of AGM
31st May 20137:00 amRNSAnnual Report
22nd Apr 20137:00 amRNSHolding(s) in Company
17th Apr 20132:44 pmRNSHolding(s) in Company
24th Jan 20132:43 pmRNSCompletion of Disposal
16th Jan 20134:49 pmRNSResult of EGM
28th Dec 20123:45 pmRNSPublication and Posting of Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.